お知らせ • Apr 01
Arjo AB (publ) to Report Fiscal Year 2026 Results on Jan 30, 2027 Arjo AB (publ) announced that they will report fiscal year 2026 results on Jan 30, 2027 お知らせ • Mar 24
Arjo AB (publ) to Report Fiscal Year 2025 Final Results on Mar 31, 2026 Arjo AB (publ) announced that they will report fiscal year 2025 final results on Mar 31, 2026 お知らせ • Mar 19
Arjo AB (Publ) Proposes Cash Dividend, Payable from 29 April 2026 The Board of Directors of Arjo AB (publ) have proposed that a dividend of SEK 0.95 per share shall be declared. As record date for the dividend, the Board proposes 24 April 2026. If the AGM resolves in accordance with the proposal, the dividend is expected to be distributed by Euroclear Sweden AB starting 29 April 2026. お知らせ • Jan 31
Arjo AB (publ), Annual General Meeting, Apr 22, 2026 Arjo AB (publ), Annual General Meeting, Apr 22, 2026. お知らせ • Jan 30
Arjo Propose Dividend for 2025 Arjo proposed a dividend per share of SEK 0.95 (0.95), corresponding to approximately SEK 259 million. お知らせ • Oct 23
Arjo AB (publ) (OM:ARJO B) acquired Slingcare B.V. for SEK 19 million. Arjo AB (publ) (OM:ARJO B) acquired Slingcare B.V. for SEK 19 million on October 1, 2025. A cash consideration of SEK 19 million will be paid by Arjo AB (publ). As part of consideration, SEK 19 million is paid towards common equity of Slingcare B.V.
For the period ending December 31, 2024, Slingcare B.V. reported total revenue of SEK 6 million.
Arjo AB (publ) (OM:ARJO B) completed the acquisition of Slingcare B.V. for SEK 19 million on October 1, 2025. お知らせ • Sep 29
Arjo AB (publ) to Report Q3, 2025 Results on Oct 22, 2025 Arjo AB (publ) announced that they will report Q3, 2025 results at 7:00 AM, Central European Standard Time on Oct 22, 2025 お知らせ • Aug 28
Arjo AB Appoints Christofer Carlsson as Permanent CFO, Effective September 1, 2025 Arjo AB announced that Christofer Carlsson, who has been interim CFO since January 20, 2025, has been appointed permanent CFO of the company starting September 1, 2025. Christofer has been with Arjo since 2017 and was previously responsible for Corporate Control, encompassing functions such as Group Accounting, Tax, and Business and Sustainability Controlling. お知らせ • Jul 11
Arjo AB (Publ) Announces Earnings Guidance for the Year 2025 Arjo AB (publ) announced earnings guidance for the year 2025. For the year, Organic sales growth is expected to be within the Group's target interval of 35%. お知らせ • May 01
Arjo AB (Publ) Provides Sales Guidance for the Year 2025 Arjo AB (publ) provided sales guidance for the year 2025. Organic sales growth for 2025 is expected to be within the Group's target interval of 3-5%. お知らせ • Apr 30
Arjo Approves Dividend for 2024, Payable from May 7, 2025 In accordance with the proposal of the Board of Directors and the CEO of Arjo AB (publ), the Annual General Meeting resolved to declare a dividend of SEK 0.95 per share 2 May 2025 was determined as record date for dividend and the dividend is expected to be distributed by Euroclear Sweden AB starting 7 May 2025. お知らせ • Apr 16
Arjo Strengthens Leading Position in Patient Handling by Introducing the New Maxi Move 5 Patient Floor Lift Arjo announced the launch of Maxi Move 5®?, the latest generation of one of the company's best-selling products. The new top-of-the-line mobile patient floor lift features several innovative technical solutions designed to help reduce caregiver injuries and optimize efficiencies in care situations. For five decades Arjo has been driving innovation within mobile patient floor lifts and remains in a leading position in the patient handling segment, and once again breaks new ground with Maxi Move 5. Patient handling remains one of Arjo's core product categories, representing approximately 26% of the company's total sales in 2024, which makes it the single largest category within the full portfolio. The launch of Maxi Move 5 is the second major product launch from Arjo in 2025, following the Symbliss®? bath system introduced earlier this year. Maxi Move 5 is intended for lifting, transferring and repositioning patients and residents within both hospitals and long-term care settings. It can also be used to facilitate hygiene care and rehabilitation exercises. The comprehensive range of unique features and functions includes the new Arjo Motion Assist®?. Operated via touch sensors on the caregiver handle that react to the carer's push, pull and pivoting motions, it enables efficient, controlled and intuitive transfers, with minimal effort from the caregiver. In addition, the Powered Dynamic Positioning System enables accurate seated positioning, supporting care flow efficiencies during transfers operated via the hand control or control panel. An independent clinical lab study shows that Maxi Move 5 reduces the accumulated forces required to complete a patient transfer by up to 68%, compared with competitor devices included in the study. Currently available in the United States, Germany, France and the Netherlands, Maxi Move 5 is scheduled to be launched in about 40 countries by the end of 2025. お知らせ • Mar 27
Arjo Announces Executive Changes Arjo has appointed Eva Brike as new EVP Human Resources & Sustainability starting June 1, 2025. Eva succeeds Marion Gullstrand, who after a long operational career has chosen to pursue new opportunities. Eva Brike most recently held the position of Vice President People & Culture at Atos Medical, part of Coloplast. She has a solid background that also includes positions at Rosti Group and Resurs Bank. Marion Gullstrand has been responsible for HR and sustainability at Arjo since before the IPO in 2017 and has previously worked for many years at Getinge. Eva Brike takes office on June 1. Marion Gullstrand will ensure a smooth transition and will leave Arjo at the end of June. お知らせ • Jan 31
Arjo AB (publ), Annual General Meeting, Apr 29, 2025 Arjo AB (publ), Annual General Meeting, Apr 29, 2025. Location: malmo Sweden お知らせ • Jan 21
Arjo Introduces Symbliss - the Next-Generation Integrated Bathing System Arjo presenting Symbliss®,an innovative assisted bathing system setting a new standard in the healthcare industry. Symbliss supports workflows that reduce caregiver injuries, optimize efficiencies in care settings and enables person-centered wellness experiences. The company has a longstanding tradition of developing hygiene solutions, with the systematic approach to both bathing and transfer equipment going back more than 50 years. Symbliss is a height-adjustable integrated bathing system consisting of a bathtub and a bath chair, with a comprehensive range of unique features and functions. The system is designed according to dementia-friendly principles and has received the highest rating from the Dementia Services Development Centre (DSDC) at the University of Stirling in Scotland. An independent study1 confirms that Arjo's Symbliss bath and chair are ergonomically safe to use by a single caregiver across mobility levels. This helps to improve efficiencies in care workflows, paving the way for time and resource savings. Symbliss is currently available in Belgium and Sweden, with launches in the US, Canada, UK and western European countries scheduled for the first quarter of 2025. お知らせ • Jan 20
Arjo Announces Chief Financial Officer Changes Arjo announced that Due to Niclas Sjöswärd taking on the role of acting CEO for Arjo following Joacim Lindoff's departure from the company, Christofer Carlsson has been appointed interim CFO, effective January 20, 2025. Christofer currently holds the position of Vice President Corporate Control at Arjo, encompassing functions such as Group Accounting, Tax, and Business and Sustainability Controlling. Christofer has been with Arjo since 2017 and has previous experience from finance positions at Gambro and BE Group among others. お知らせ • Jan 15
Arjo AB (Publ) Announces CEO Changes Arjo AB (publ) announced The Board of Directors of Arjo and Joacim Lindoff have come to an agreement which implicates Joacim leaving his position as CEO of Arjo, a role he has held since 2017. Niclas Sjöswärd, currently CFO of Arjo, has been appointed interim CEO. The process of recruiting a new CEO will be initiated immediately. お知らせ • Jan 14
Arjo AB (Publ) Announces Resignation of Joacim Lindoff as President Arjo AB (publ) announced The Board of Directors of Arjo and Joacim Lindoff have come to an agreement which implicates Joacim leaving his position as President of Arjo, a role he has held since 2017. Niclas Sjöswärd, currently CFO of Arjo, has been appointed interim President. お知らせ • Sep 25
Arjo AB (publ) (OM:ARJO B) signed an agreement to acquire TECH MED. Arjo AB (publ) (OM:ARJO B) signed an agreement to acquire TECH MED on September 24, 2024. As of 2023, Tech Med had a turnover of approximately €2.25 million.
The closing of the acquisition of Tech Med is subject to customary approvals from authorities which are expected during the fourth quarter of 2024. お知らせ • Sep 24
Arjo AB (publ) (OM:ARJO B) agreed to acquire GerroMed GmbH. Arjo AB (publ) (OM:ARJO B) agreed to acquire GerroMed GmbH on September 24, 2024.
For the period ending December 31, 2023, GerroMed GmbH reported total revenue of SEK 30 million.
The transaction is subject to approval by regulatory board / committee. The transaction is expectd to be completed in the fourth quarter of 2024. お知らせ • Jul 12
Arjo AB (Publ) Provides Organic Net Sales Guidance for the Full Year 2024 Arjo AB (publ) provided organic net sales guidance for the full year 2024. The outlook 2024, where, given the solid start in the first half year, continue to guide for an organic net sales increase well within target interval of 3% to 5%. Based on this solid start to the year, the company feel comfortable with the organic net sales outlook for the full year. お知らせ • May 18
Arjo Provides Sales Guidance for the Year 2024 Arjo provided sales guidance for the year 2024. For the year, the company expects organic net sales growth to be between 3% to 5%. お知らせ • Mar 13
Arjo AB (Publ) Proposes Dividend, Payable on 25 April 2024 The Board of Arjo AB (publ) and the CEO have proposed that a dividend of SEK 0.90 per share shall be declared. As record date for the dividend, the Board proposes 22 April 2024. If the AGM resolves in accordance with the proposal, the dividend is expected to be distributed by Euroclear Sweden AB starting 25 April 2024. お知らせ • Jan 31
Arjo AB (publ) to Report Fiscal Year 2023 Final Results on Mar 21, 2024 Arjo AB (publ) announced that they will report fiscal year 2023 final results at 9:00 AM, Central European Standard Time on Mar 21, 2024 お知らせ • Oct 20
Arjo AB (Publ) Provides Financial Outlook for 2023 Arjo AB (publ) provided financial outlook for 2023. For the period company expected, based on current visibility of the market, the organic net sales growth for 2023 to be within the group's target interval of 3% to 5%. The company continue to expect 2023 to be a year with net sales and profitability improvements versus 2022. お知らせ • May 09
Arjo AB (publ) Announces Resignation of Daniel Fäldt as CFO Arjo AB (publ) announced that CFO Daniel Fäldt has due to family reasons decided to leave his position as CFO and member of the Arjo Management team with immediate effect. The process to find a successor starts immediately. Until a successor is in place, Joacim Lindoff, President & CEO, will hold the interim responsibility for the Group's finance function. お知らせ • Jan 26
Arjo AB (publ) Proposes Dividend for the Year 2022, Payable on April 27, 2023 Arjo AB (publ) proposed dividend per share of SEK 0.85 (SEK 1.15) for the year 2022. The total dividend thus amounts to SEK 232 million compared to SEK 313 million an year ago. The Board's proposed record date is April 24, 2023. Euroclear expects to distribute the dividend to shareholders from April 27, 2023. お知らせ • Jan 25
Arjo AB (publ) Provides Organic Sales Guidance for the Year 2023 Arjo AB (publ) provided organic sales guidance for the year 2023. The company expects an organic sales growth for 2023 in line with its 3-5% target. お知らせ • Jul 14
Arjo AB (publ) to Report Fiscal Year 2022 Results on Jan 25, 2023 Arjo AB (publ) announced that they will report fiscal year 2022 results on Jan 25, 2023